US EditionRingCentral A Stock for Patient Investors, AI Tools And New Products Show Early Promise: Analyst - RingCentral (NYSE:RNG)
Summary by Benzinga
1 Articles
1 Articles
All
Left
Center
1
Right
RingCentral A Stock for Patient Investors, AI Tools And New Products Show Early Promise: Analyst - RingCentral (NYSE:RNG)
Rosenblatt analyst Catharine Trebnick maintained RingCentral (NYSE:RNG) with a Buy and lowered the price forecast from $40 to $28 on Thursday. Trebnick reduced her price forecast due to lower revenue projections for fiscal 2025 and 2026, reflecting ongoing economic uncertainty and recent leadership transitions. The analyst remarked RingCentral as a stock for patient investors. Also Read: Zoom Shares Rise After Global Outage Reminds Investors of …
·New York, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
